XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Common Stock (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 16, 2022
Jan. 14, 2022
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 09, 2022
Dec. 31, 2021
Apr. 30, 2019
Subsidiary, Sale of Stock [Line Items]                
Common stock, shares authorized     250,000,000 250,000,000     250,000,000 250,000,000
Deferred offering costs         $ 546,651  
Share-based payment award, options, outstanding, number     1,628,813 1,628,813     903,468  
Debt conversion, converted instrument, amount       $ 3,734,446      
Stock issued during period, value, issued for services       $ 100,000        
Number of shares authorized repurchased           1,000,000.0    
Purchase of treasury stock at cost, shares     45,109 75,109        
Purchase of treasury stock at cost     $ 37,444 $ 62,147        
Consulting Services Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Shares issued, price per share $ 3.15              
Stock issued during period, shares, issued for services 31,746              
Stock issued during period, value, issued for services $ 100,000              
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Stock issued during period, shares, new issues   3,750,000            
Shares issued, price per share   $ 4.00            
Gross proceeds from issuance initial public offering   $ 15,000,000.0            
Underwriting discount   1,100,000            
Commissions and other offering expenses   1,000,000.0            
Deferred offering costs   547,000            
Proceeds from issuance initial public offering   $ 13,000,000.0   $ 13,000,000.0        
Share-based payment award, options, outstanding, number   562,500            
Debt conversion, converted instrument, shares issued   1,225,384            
IPO [Member] | Principal Amount [Member]                
Subsidiary, Sale of Stock [Line Items]                
Debt conversion, converted instrument, amount   $ 3,700,000            
IPO [Member] | Accrued Interest [Member]                
Subsidiary, Sale of Stock [Line Items]                
Debt conversion, converted instrument, amount   187,000            
IPO [Member] | Redemption Liability [Member]                
Subsidiary, Sale of Stock [Line Items]                
Debt conversion, converted instrument, amount   $ 980,000